ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

Pollin Prize honors four pioneers in treatment of childhood leukemia.

December 12, 2003

Broder Explains Where R01 Money Has Gone

July 20, 1990